| Biological Information | |
|---|---|
| Background Information: | Interaction of the IgSF family ligand, PD-L1, with its receptor, PD-1, inhibits T-cell proliferation and cytokine production, and down-regulates the immune response. Provided as 100 μg of antibody in buffer. |
| Target Class: | Checkpoint Receptor |
| Family: | IgSF (immune inhibitory Receptor ligand) |
| Target Name: | PD-L1 |
| Usage | |
| Product Type: | Antibodies |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at -20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
| Additional Information | |
| Brand: | DiscoverX |
Anti-PD-L1 antibody
Anti-PD-L1 Antibody is an antibody acting as an agonist for PD-L1 dimerization. This product is provided as 100μg of antibody in buffer.
Datasheets
92-1340 Datasheet
View Document